MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:229643 chebi:229643 JJVAPHYEOZSKJZ-JGCGQSQUSA-N | zavegepant (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide BHV 3500 BHV-3500 BHV3500 BMS 742413 BMS-742413 BMS-742413-01 N-{(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl}-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide zavegepantum |
kegg.drug:D11898 keggD:D11898 JJVAPHYEOZSKJZ-JGCGQSQUSA-N | Zavegepant (USAN) |
CHEBI:229645 chebi:229645 JJVAPHYEOZSKJZ-JGCGQSQUSA-O | zavegepant(1+) 1-methyl-4-{4-[(2R)-3-(7-methyl-1H-indazol-5-yl)-2-({[4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidin-1-yl]carbonyl}amino)propanoyl]piperazin-1-yl}piperidinium zavegepant cation |
keggD:M_D11898 | secondary/obsolete/fantasy identifier |